Enveric Biosciences (ENVB) Change in Accured Expenses (2011 - 2026)
Enveric Biosciences' Change in Accured Expenses was $419,025 in Q2 2026, up 44.5% from $289,981 a year earlier.
Powered by 
Analysis
Enveric Biosciences (ENVB) Change in Accured Expenses (2011 - 2026) Analysis & Trends
On a trailing twelve-month basis, Enveric Biosciences' Change in Accured Expenses was -$400,929 through Jun 30, 2026; for FY2025, it was -$413,864.
- In earlier years, Change in Accured Expenses was -$834,630 in FY2024, -$103,848 in FY2023, $263,686 in FY2022 (-31.2%) and $383,199 in FY2021 (+43.5%).
- The Q2 2026 figure marks the highest quarterly Change in Accured Expenses since Q4 2024.
- Per Business Quant data, ENVB's Change in Accured Expenses in the three quarters before Q2 2026 was -$417,390 (Q1 2026), -$117,882 (Q4 2025) and -$284,682 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 2.96 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 1.20 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | -251.00 Mn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | - |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 901.00 Mn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 338.00 Mn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | - |
| 10 | Enveric Biosciences | 5.75 Mn | -15.89 Mn | - | 419,025.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 419,025.00 |
| Mar 31, 2026 | -417,390.00 |
| Dec 31, 2025 | -117,882.00 |
| Sep 30, 2025 | -284,682.00 |
| Jun 30, 2025 | 289,981.00 |
| Mar 31, 2025 | -301,281.00 |
| Dec 31, 2024 | 462,277.00 |
| Sep 30, 2024 | 161,763.00 |
| Jun 30, 2024 | -1.66 Mn |
| Mar 31, 2024 | 202,397.00 |
| Dec 31, 2023 | -533,536.00 |
| Sep 30, 2023 | -112,709.00 |
| Jun 30, 2023 | -111,315.00 |
| Mar 31, 2023 | 653,712.00 |
| Dec 31, 2022 | 370,361.00 |
| Sep 30, 2022 | 81,227.00 |
| Jun 30, 2022 | -193,923.00 |
| Mar 31, 2022 | 6,021.00 |
| Dec 31, 2021 | -242,549.00 |
| Sep 30, 2021 | 139,474.00 |
API Access
Enveric Biosciences Change in Accured Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=ENVB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "ENVB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=ENVB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();